Viewing StudyNCT00117247



Ignite Creation Date: 2024-05-05 @ 11:43 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00117247
Status: COMPLETED
Last Update Posted: 2009-10-16
First Post: 2005-06-30

Brief Title: A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia and a Single Dose in Healthy Age- and Sex-Matched Control Subjects
Sponsor:
Organization: Amgen

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: None
Enrollment Type: None
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
PHASE1
Observational Models:
Time Perspective List:
Who Masked List: